Changeflow GovPing Pharma & Drug Safety EPO Patent Application: Enforced Mitophagy System
Routine Notice Added Final

EPO Patent Application: Enforced Mitophagy System

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published patent application EP2026030758A2 concerning an enforced mitophagy system designed to reduce mitochondrial abundance in cells and organisms. The application details a method for controlling mitochondrial levels, potentially impacting biotechnology and medical research fields.

What changed

The European Patent Office (EPO) has published patent application EP2026030758A2, titled "AN ENFORCED MITOPHAGY SYSTEM TO REDUCE MITOCHONDRIAL ABUNDANCE FROM CELLS AND ORGANISMS." This publication, dated March 18, 2026, describes a system and method for regulating mitochondrial abundance within cells and organisms. The application is classified under IPC codes C12N 5/0735 and C12N 15/10, indicating its relevance to cell biology and genetic engineering.

This patent application does not impose immediate compliance obligations on regulated entities. However, it represents a development in biotechnology that may influence future research, product development, and intellectual property strategies for companies in the pharmaceutical, biotechnology, and medical device sectors. Compliance officers should note this publication as a potential indicator of emerging technologies in cellular health and therapeutic interventions.

Source document (simplified)

← EPO Patent Bulletin

AN ENFORCED MITOPHAGY SYSTEM TO REDUCE MITOCHONDRIAL ABUNDANCE FROM CELLS AND ORGANISMS

Publication EP2026030758A2 Kind: A2 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C12N 5/0735 20100101AFI20260208BHEP C12N 15/10 20060101ALI20260208BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

AN ENFORCED MITOPHAGY SYSTEM TO REDUCE MITOCHONDRIAL ABUNDANCE FROM CELLS AND ORGANISMS

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026030758A2

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Biotechnology Research Drug Development
Geographic scope
European Union EU

Taxonomy

Primary area
Healthcare
Operational domain
Research & Development
Topics
Biotechnology Medical Research

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.